Your top networking opportunities for the month of March.
latest articles
A once-projected shortfall transformed into a $329 million surplus in Wednesday's updated forecast. The problem? Everyone expected that number to be much bigger.
The electronics company's same-store sales jumped 9 percent during the holiday period, an incredible feat for any retailer in today's retail climate.
The public radio network is investing in new programming, technology and talent.
It starts by not supporting it, even if it is entertaining or ‘for good reason.’
The new tax law requires nonprofits to rethink their case for support.
Employers should check out ‘outcomes-based’ contracts with drug
companies—you pay only when their high-priced specialty drugs work as promised.
A yoga instructor takes an animated approach to teaching children the benefits of exercise.
But growth in health savings accounts to help pay for high deductibles may be slowing.
Sonex Health of Rochester and Oculogics of Minneapolis land initial venture backing.
The mixed public-private effort with Vaccinex is aiming to bring about a treatment for intractable osteosarcoma.
The deal, which largely involves Surmodics' SurVeil drug-coated balloon, would give Abbott worldwide commercialization rights once the device receives FDA approval.
[Reps. Emmer,
Lewis and Paulsen:]
Why don’t the three of you simply introduce legislation that rebates to each state the differential from what that state pays into the federal fisc, minus what it receives back?
The deal marked General Mills re-entry into the pet food industry.
The imaging company reported nearly $5 million in sales in its fourth quarter, but capped the year with an overall loss of nearly a quarter-million dollars.
Business is booming for the Baudette-based drug maker.